Cargando…
(99m)Tc-rituximab tracer injection for guiding internal mammary sentinel lymph nodes biopsy in primary breast cancer: A prospective observational study
OBJECTIVE: To explore the use of (99m)Tc-rituximab tracer injection for internal mammary sentinel lymph node (IM-SLN) detection in patients with primary breast cancer. METHODS: This prospective observational study enrolled female patients with primary breast cancer between September 2017 and June 20...
Autores principales: | Chen, Wenxin, Su, Yaodong, Zhang, Hui, Zhang, Yu, Zhu, Lin, Lin, Mengbo, Lin, Zhiyi, Yu, Mingdian, Yang, Shengping, Zhang, Yanmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950501/ https://www.ncbi.nlm.nih.gov/pubmed/36845718 http://dx.doi.org/10.3389/fonc.2023.1100077 |
Ejemplares similares
-
The efficacy of (99m)Tc-rituximab as a tracer for sentinel lymph node biopsy in cutaneous melanoma patients
por: Liu, Jiayong, et al.
Publicado: (2022) -
Head-to-head comparison of (99m)Tc-PSMA and (99m)Tc-MDP SPECT/CT in diagnosing prostate cancer bone metastasis: a prospective, comparative imaging trial
por: Zhang, Yu, et al.
Publicado: (2022) -
Comparative research on (99m)Tc-Rituximab and (99m)Tc-sulfur colloid in sentinel lymph node imaging of breast cancer
por: Zhang, Jing-Jie, et al.
Publicado: (2019) -
Technetium-99m-labeled rituximab for use as a specific tracer of sentinel lymph node biopsy: a translational research study
por: Wang, Xuejuan, et al.
Publicado: (2016) -
Can (99)Tc(m)-3PRGD(2)(α(ν)β(3)) and (18)F-FDG dual-tracer molecular imaging change the therapeutic strategy for progressive refractory differentiated thyroid cancer: Case report
por: Zhang, Yu, et al.
Publicado: (2023)